Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Airway obstruction due to bronchial vascular injury after sulfur mustard analog inhalation.

Veress LA, O'Neill HC, Hendry-Hofer TB, Loader JE, Rancourt RC, White CW.

Am J Respir Crit Care Med. 2010 Dec 1;182(11):1352-61. doi: 10.1164/rccm.200910-1618OC. Epub 2010 Jul 16.

2.

REACTION OF ENZYMES AND PROTEINS WITH MUSTARD GAS (BIS(beta-CHLOROETHYL)SULFIDE).

Herriott RM, Anson ML, Northrop JH.

J Gen Physiol. 1946 Nov 20;30(2):185-210.

3.

Inhalation exposure to sulfur mustard in the guinea pig model: clinical, biochemical and histopathological characterization of respiratory injuries.

Allon N, Amir A, Manisterski E, Rabinovitz I, Dachir S, Kadar T.

Toxicol Appl Pharmacol. 2009 Dec 1;241(2):154-62. doi: 10.1016/j.taap.2009.08.006. Epub 2009 Aug 12.

PMID:
19682477
4.

A clinical evaluation committee assessment of recombinant human tissue factor pathway inhibitor (tifacogin) in patients with severe community-acquired pneumonia.

Laterre PF, Opal SM, Abraham E, LaRosa SP, Creasey AA, Xie F, Poole L, Wunderink RG.

Crit Care. 2009;13(2):R36. doi: 10.1186/cc7747. Epub 2009 Mar 15.

5.

Intra-alveolar tissue factor pathway inhibitor is not sufficient to block tissue factor procoagulant activity.

Bastarache JA, Wang L, Wang Z, Albertine KH, Matthay MA, Ware LB.

Am J Physiol Lung Cell Mol Physiol. 2008 May;294(5):L874-81. doi: 10.1152/ajplung.00372.2007. Epub 2008 Feb 29.

6.

Membrane environment rather than tissue factor expression determines thrombin formation triggered by monocytic cells undergoing apoptosis.

Stampfuss JJ, Censarek P, Bein D, Schrör K, Grandoch M, Naber C, Weber AA.

J Leukoc Biol. 2008 Jun;83(6):1379-81. doi: 10.1189/jlb.1207843. Epub 2008 Feb 27.

7.

Aerosolized anticoagulants ameliorate acute lung injury in sheep after exposure to burn and smoke inhalation.

Enkhbaatar P, Cox RA, Traber LD, Westphal M, Aimalohi E, Morita N, Prough DS, Herndon DN, Traber DL.

Crit Care Med. 2007 Dec;35(12):2805-10.

PMID:
18074480
8.

Chemotherapy-induced thrombin generation via procoagulant endothelial microparticles is independent of tissue factor activity.

Lechner D, Kollars M, Gleiss A, Kyrle PA, Weltermann A.

J Thromb Haemost. 2007 Dec;5(12):2445-52. Epub 2007 Oct 8.

9.

Lactadherin deficiency leads to apoptotic cell accumulation and accelerated atherosclerosis in mice.

Ait-Oufella H, Kinugawa K, Zoll J, Simon T, Boddaert J, Heeneman S, Blanc-Brude O, Barateau V, Potteaux S, Merval R, Esposito B, Teissier E, Daemen MJ, Lesèche G, Boulanger C, Tedgui A, Mallat Z.

Circulation. 2007 Apr 24;115(16):2168-77. Epub 2007 Apr 9.

10.

Basal cells of the human adult airway surface epithelium retain transit-amplifying cell properties.

Hajj R, Baranek T, Le Naour R, Lesimple P, Puchelle E, Coraux C.

Stem Cells. 2007 Jan;25(1):139-48. Epub 2006 Sep 28.

11.

Tissue factor encryption.

Bach RR.

Arterioscler Thromb Vasc Biol. 2006 Mar;26(3):456-61. Epub 2006 Jan 5. Review.

12.

Attenuation of half sulfur mustard gas-induced acute lung injury in rats.

McClintock SD, Hoesel LM, Das SK, Till GO, Neff T, Kunkel RG, Smith MG, Ward PA.

J Appl Toxicol. 2006 Mar-Apr;26(2):126-31.

PMID:
16252256
13.

History of chemical and biological warfare agents.

Szinicz L.

Toxicology. 2005 Oct 30;214(3):167-81.

PMID:
16111798
14.

Genomic analysis of rodent pulmonary tissue following bis-(2-chloroethyl) sulfide exposure.

Dillman JF 3rd, Phillips CS, Dorsch LM, Croxton MD, Hege AI, Sylvester AJ, Moran TS, Sciuto AM.

Chem Res Toxicol. 2005 Jan;18(1):28-34.

PMID:
15651846
15.

Protection by antioxidants against toxicity and apoptosis induced by the sulphur mustard analog 2-chloroethylethyl sulphide (CEES) in Jurkat T cells and normal human lymphocytes.

Han S, Espinoza LA, Liao H, Boulares AH, Smulson ME.

Br J Pharmacol. 2004 Mar;141(5):795-802. Epub 2004 Feb 9. Erratum in: Br J Pharmacol. 2004 May;142(1):229.

16.

Airway obstruction in sheep with burn and smoke inhalation injuries.

Cox RA, Burke AS, Soejima K, Murakami K, Katahira J, Traber LD, Herndon DN, Schmalstieg FC, Traber DL, Hawkins HK.

Am J Respir Cell Mol Biol. 2003 Sep;29(3 Pt 1):295-302.

PMID:
12936906
17.

Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial.

Abraham E, Reinhart K, Opal S, Demeyer I, Doig C, Rodriguez AL, Beale R, Svoboda P, Laterre PF, Simon S, Light B, Spapen H, Stone J, Seibert A, Peckelsen C, De Deyne C, Postier R, Pettilä V, Sprung CL, Artigas A, Percell SR, Shu V, Zwingelstein C, Tobias J, Poole L, Stolzenbach JC, Creasey AA; OPTIMIST Trial Study Group.

JAMA. 2003 Jul 9;290(2):238-47.

PMID:
12851279
18.

Blockade of tissue factor: treatment for organ injury in established sepsis.

Carraway MS, Welty-Wolf KE, Miller DL, Ortel TL, Idell S, Ghio AJ, Petersen LC, Piantadosi CA.

Am J Respir Crit Care Med. 2003 May 1;167(9):1200-9.

PMID:
12714343
19.

Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.

Idell S.

Crit Care Med. 2003 Apr;31(4 Suppl):S213-20. Review.

PMID:
12682443
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk